The Coalition for Epidemic Preparedness Innovations (CEPI) is partnering with Jurata Thin Film, Inc. (Jurata) to create a thermostable mRNA vaccine film that will be delivered under the patient's tongue.
Pharmaceutical giant says its vaccine only "may be" effective in reducing "severe disease and hospitalization," and falls short of confirming protection from infection.
